Bristol-Myers SquibbPublication
Bristol-Myers Squibb publishes application for compounds modulating RET protein.
The filing
Bristol-Myers Squibb published an application on November 12, 2026, for compounds designed to modulate the RET protein. The application, titled "COMPOUNDS FOR MODULATING RET PROTEIN," is available at US20260356830A1 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.